The Discounted Cash Flow (DCF) valuation of Biodesix, Inc. (BDSX) is (109.01) USD. With the latest stock price at 14.76 USD, the upside of Biodesix, Inc. based on DCF is -838.6%.
Based on the latest price of 14.76 USD and our DCF valuation, Biodesix, Inc. (BDSX) is a sell. selling Biodesix, stocks now will result in a potential gain of 838.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 9.7% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (568.71) - (63.20) | (109.01) |
| Upside | -3953.0% - -528.2% | -838.6% |